| Reaves Dental Practice, Pllc | |
|
4301 Middle Settlement Rd New Hartford NY 13413-5317 | |
| (315) 736-0139 | |
| (315) 768-6148 |
| Full Name | Reaves Dental Practice, Pllc |
|---|---|
| Speciality | Clinic/Center |
| Location | 4301 Middle Settlement Rd, New Hartford, New York |
| Authorized Official Name and Position | Justin J Reaves (OWNER - GENERAL DENTIST) |
| Authorized Official Contact | 3157360139 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Reaves Dental Practice, Pllc 4301 Middle Settlement Rd New Hartford NY 13413-5317 Ph: (315) 736-0139 | Reaves Dental Practice, Pllc 4301 Middle Settlement Rd New Hartford NY 13413-5317 Ph: (315) 736-0139 |
| NPI Number | 1124264866 |
|---|---|
| Provider Enumeration Date | 12/31/2008 |
| Last Update Date | 11/05/2014 |
| Medicare PECOS PAC ID | 5294052924 |
|---|---|
| Medicare Enrollment ID | O20150318000152 |
News Archive
The pivotal trial to determine the safety and effectiveness of a modular device designed to be the first completely off-the-shelf endovascular solution for aortic aneurysms involving the visceral branch vessels is successfully underway with its first surgery at UNC Hospitals in Chapel Hill, NC.
A Yale-led team of researchers have created a vaccine that protects against malaria infection in mouse models, paving the way for the development of a human vaccine that works by targeting the specific protein that parasites use to evade the immune system.
Hereditary angioedema (HAE) can be difficult to accurately diagnose and equally difficult to effectively treat. To overcome the many obstacles to managing the care of patients with HAE, healthcare professionals must be aware of the most up-to-date clinical data regarding HAE diagnosis and treatment.
Researchers at Brigham and Women's Hospital (BWH) have identified a new combination of targeted therapies that, together, may treat two aggressive tumor types that until now have not had effective treatments. These findings are published in Cancer Cell on September 13, 2011.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124264866 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QD0000X | Clinic/center - Dental | 032955 (New York) | Secondary |
| 261QD0000X | Clinic/center - Dental | 053015 (New York) | Primary |
| Provider Name | Justin J Reaves |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1740383256 PECOS PAC ID: 6800113531 Enrollment ID: I20150320000086 |
News Archive
The pivotal trial to determine the safety and effectiveness of a modular device designed to be the first completely off-the-shelf endovascular solution for aortic aneurysms involving the visceral branch vessels is successfully underway with its first surgery at UNC Hospitals in Chapel Hill, NC.
A Yale-led team of researchers have created a vaccine that protects against malaria infection in mouse models, paving the way for the development of a human vaccine that works by targeting the specific protein that parasites use to evade the immune system.
Hereditary angioedema (HAE) can be difficult to accurately diagnose and equally difficult to effectively treat. To overcome the many obstacles to managing the care of patients with HAE, healthcare professionals must be aware of the most up-to-date clinical data regarding HAE diagnosis and treatment.
Researchers at Brigham and Women's Hospital (BWH) have identified a new combination of targeted therapies that, together, may treat two aggressive tumor types that until now have not had effective treatments. These findings are published in Cancer Cell on September 13, 2011.
› Verified 3 days ago
| Provider Name | Glenn A Reaves |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1376542399 PECOS PAC ID: 2163749896 Enrollment ID: I20150320000141 |
News Archive
The pivotal trial to determine the safety and effectiveness of a modular device designed to be the first completely off-the-shelf endovascular solution for aortic aneurysms involving the visceral branch vessels is successfully underway with its first surgery at UNC Hospitals in Chapel Hill, NC.
A Yale-led team of researchers have created a vaccine that protects against malaria infection in mouse models, paving the way for the development of a human vaccine that works by targeting the specific protein that parasites use to evade the immune system.
Hereditary angioedema (HAE) can be difficult to accurately diagnose and equally difficult to effectively treat. To overcome the many obstacles to managing the care of patients with HAE, healthcare professionals must be aware of the most up-to-date clinical data regarding HAE diagnosis and treatment.
Researchers at Brigham and Women's Hospital (BWH) have identified a new combination of targeted therapies that, together, may treat two aggressive tumor types that until now have not had effective treatments. These findings are published in Cancer Cell on September 13, 2011.
› Verified 3 days ago
News Archive
The pivotal trial to determine the safety and effectiveness of a modular device designed to be the first completely off-the-shelf endovascular solution for aortic aneurysms involving the visceral branch vessels is successfully underway with its first surgery at UNC Hospitals in Chapel Hill, NC.
A Yale-led team of researchers have created a vaccine that protects against malaria infection in mouse models, paving the way for the development of a human vaccine that works by targeting the specific protein that parasites use to evade the immune system.
Hereditary angioedema (HAE) can be difficult to accurately diagnose and equally difficult to effectively treat. To overcome the many obstacles to managing the care of patients with HAE, healthcare professionals must be aware of the most up-to-date clinical data regarding HAE diagnosis and treatment.
Researchers at Brigham and Women's Hospital (BWH) have identified a new combination of targeted therapies that, together, may treat two aggressive tumor types that until now have not had effective treatments. These findings are published in Cancer Cell on September 13, 2011.
› Verified 3 days ago
Stephen H. Passalacqua Dds Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 3 1/2 Oxford Rd, New Hartford, NY 13413 Phone: 315-724-1597 Fax: 315-724-6130 | |
Allcare Dental & Dentures Of Ny Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 4825 Commercial Dr, New Hartford, NY 13413 Phone: 315-768-1063 Fax: 313-768-1095 | |
Kidsteethonly Pediatric Dentistry, Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 100 Genesee St, New Hartford, NY 13413 Phone: 315-724-5437 | |
Tiffany Sreca, D.m.d., P.c. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 2 Ellinwood Dr, New Hartford, NY 13413 Phone: 315-732-5100 | |
Glenn A Reaves Dds Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 4301 Middle Settlement Rd, New Hartford, NY 13413 Phone: 315-736-0139 Fax: 315-768-6148 | |
The Dental Office Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 4484 Commercial Dr, New Hartford, NY 13413 Phone: 315-736-7777 Fax: 315-736-6919 |